✦ LIBER ✦

SP161 NNBC3 Europe – Evaluation of the ASCO recommended prognostic factors uPA/PAI-1 in node negative breast cancer patients

✍ Scribed by C. Thomssen

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

0058 Determination of ASCO recommended p

✍ C. Thomssen; M. Vetter; E. Kantelhardt; A. Geurts-Moespot; M. Schmidt; C. Veyret 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Prospective evaluation of prognostic fac

✍ Eva J Kantelhardt; Martina Vetter; Marcus Schmidt; Corinne Veyret; Doris Augusti 📂 Article 📅 2011 🏛 BioMed Central 🌐 English ⚖ 292 KB

Health economic impact of risk group sel

✍ Jacobs, Volker R.; Kates, Ronald E.; Kantelhardt, Eva; Vetter, Martina; Wuerstle 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 385 KB

Urokinase-type plasminogen activator (uP

✍ C. Thomssen; M. Vetter; D. Paepke; M. Schmidt; C. Veyret; D. Augustin; V. Hanf; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 75 KB

P180 Molecular types, uPA/PAI-1, clinica

✍ E.J. Kantelhardt; M. Vetter; K. Spinda; A. Lingner; M. Schmidt; P.M. Martin; R. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 40 KB

Level-I evidence for prognostic impact o

✍ C. Thomssen; N. Harbeck; C. Meisner; A. Prechtl; M. Untch; B. Lisboa; H. Selbman 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 198 KB